Pharma stock play


PETALING JAYA: Rubber glove makers have taken a step back from their dominance of the stock exchange to pave way for pharmaceutical companies, following a shift in interest among investors.

Two research trials in China and the United Kingdom which yielded positive results drove investors into a frenzy to enter pharmaceutical-related companies, not only on Bursa Malaysia but also in key markets globally.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Bursa Malaysia closed for Thaipusam, FT day on Feb 2
Stocks slide, dollar struggles as Trump's Greenland gambit rattles markets
US yields rise to multi-month highs on Trump's tariff threats
OMS Group inks deal with Ulstein for two next-generation cable-laying vessels
Ringgit firmer vs greenback on rising US-EU tensions
FBM KLCI retreats to 1,700 support as profit-taking accelerates
Trading ideas: IJM, Perak Corp, Kuchai, Favelle Favco, Reservoir Link, OpenSys, Teladan, PJBumi, AirAsia X, M&A Equity, Alliance Bank
Cypark aims for stronger recurring income stream
Iran’s real oil risk is labour strikes, not bombs
Coconuts might be IOI Corp’s next cash crop

Others Also Read